Meds & supplements › Vilanterol
Medicine
The following clinically significant adverse reactions are described elsewhere in labeling:
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice.
BREO ELLIPTA is contraindicated in the following conditions:
sofidex [Internet]. Daloreum; c2026. Vilanterol; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/vilanterol
sofidex. (2026, August 3). Vilanterol. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/vilanterol
Vilanterol. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/vilanterol
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.